HOW SHOULD WE USE METRONIDAZOLE

被引:4
作者
ELLIS, CJ
机构
关键词
D O I
10.1093/jac/6.3.305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:305 / 307
页数:3
相关论文
共 15 条
[1]   BACTEREMIC BACTEROIDES INFECTIONS [J].
BODNER, SJ ;
KOENIG, MG ;
GOODMAN, JS .
ANNALS OF INTERNAL MEDICINE, 1970, 73 (04) :537-+
[2]   METRONIDAZOLE NEUROPATHY [J].
BRADLEY, WG ;
KARLSSON, IJ ;
RASSOL, CG .
BRITISH MEDICAL JOURNAL, 1977, 2 (6087) :610-611
[3]  
BUCHFELD P, 1978, SCANDINAVIAN J GASTR, V13, P123
[4]   INACTIVATION OF METRONIDAZOLE BY AEROBIC ORGANISMS [J].
EDWARDS, DI ;
THOMPSON, EJ ;
TOMUSANGE, J ;
SHANSON, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1979, 5 (03) :315-316
[5]  
EYKYN, 1979, LANCET, V2, P761
[6]  
GOLDRING J, 1975, LANCET, V2, P997
[7]  
INGHAM HR, 1978, LANCET, V1, P214
[8]   METABOLISM OF METRONIDAZOLE (1-2'-HYDROXYETHYL-2-METHYL-5-NITROIMIDAZOLE) [J].
INGS, RMJ ;
LAW, GL ;
PARNELL, EW .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (05) :515-&
[9]   PENETRATION OF BLOOD-BRAIN BARRIER BY METRONIDAZOLE AND TINIDAZOLE [J].
JOKIPII, AMM ;
MYLLYLA, VV ;
HOKKANEN, E ;
JOKIPII, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (03) :239-245
[10]  
KEIGHLEY MRB, 1979, LANCET, V1, P894